Stocktoria

Arcturus Therapeutics Holdings Inc. ARCT

Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2013-05-22
Chart by TradingView
1/9
Piotroski F — financial health
0.81
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$82.0M$152.3M$166.8M$206.0M$12.4M
Operating income-$76.3M-$95.7M-$78.2M$12.2M-$202.9M
Net income-$65.8M-$80.9M-$29.7M$9.3M-$203.7M
Operating cash flow-$74.3M-$59.7M-$18.1M$32.0M-$135.0M
Free cash flow-$74.5M-$60.4M-$21.0M$24.3M-$138.4M
Total assets$271.1M$344.1M$429.4M$450.4M$392.8M
Total liabilities$57.2M$103.1M$150.9M$180.1M$164.6M
Shareholders' equity$214.0M$241.0M$278.5M$270.3M$228.2M
Ratios
Operating margin-93.0%-62.8%-46.9%5.9%-1641.3%
Net margin-80.2%-53.1%-17.8%4.5%-1648.0%
FCF margin-90.8%-39.7%-12.6%11.8%-1120.2%
Return on assets-24.3%-23.5%-6.9%2.1%-51.8%
Return on equity-30.7%-33.6%-10.7%3.5%-89.2%
Debt / equity0.18×
Current ratio6.644.674.723.183.81
Revenue growth-46.1%-8.7%-19.0%1566.8%29.6%

Notable holders (13F)

InvestorSharesValue
ARK Investment Management LLC2,769,518$21.4M
RENAISSANCE TECHNOLOGIES LLC178,300$1.4M
Point72 Asset Management, L.P.63,845$492,883

Why these scores methodology →

Piotroski F-score: 1/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 0.81 (distress)

  • Working capital / assets 0.756
  • Retained earnings / assets -1.898
  • EBIT / assets -0.281
  • Equity / liabilities 3.743

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001768224 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.